Overview Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients Status: Completed Trial end date: 2013-10-01 Target enrollment: Participant gender: Summary A multiple dose relative bioavailability study in patients with prostate cancer comparing a capsule and a tablet formulation of enzalutamide. Phase: Phase 1 Details Lead Sponsor: Astellas Pharma Europe B.V.Collaborator: Medivation, Inc.